Saba Capital Management, L.P. 13D and 13G filings for CERo Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 12:31 pm Sale |
2023-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO |
Saba Capital Management, L.P. | 0 0.000% |
-12,124 (Position Closed) |
Filing |
| 2023-02-14 06:39 am Purchase |
2022-12-31 | 13G | CERo Therapeutics Holdings, Inc. CERO |
Saba Capital Management, L.P. | 12,124 6.600% |
2,550 (+26.63%) |
Filing |
| 2022-05-06 4:53 pm Purchase |
2022-04-28 | 13G | CERo Therapeutics Holdings, Inc. CERO |
Saba Capital Management, L.P. | 9,574 5.200% |
9,574 (New Position) |
Filing |